FDA Inspection
Rowena Punzalan, M.D.Rowena Punzalan, M.D. – FDA Inspection, Feb 7, 2025
Record Details
This FDA Inspection record concerns Rowena Punzalan, M.D., with an inspection on February 7, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 962b5cf4-0627-402e-bc0f-8002e82b2e12
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1260284
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Unanticipated problems
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rowena Punzalan, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Rowena Punzalan, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.